4.6 Article

Donor interleukin-22 and host type I interferon signaling pathway participate in intestinal graft-versus-host disease via STAT1 activation and CXCL10

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Interleukin-22 Aggravates Murine Acute Graft-Versus-Host Disease by Expanding Effector T Cell and Reducing Regulatory T Cell

Kai Zhao et al.

JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2014)

Article Pharmacology & Pharmacy

IFNα converts IL-22 into a cytokine efficiently activating STAT1 and its downstream targets

Malte Bachmann et al.

BIOCHEMICAL PHARMACOLOGY (2013)

Review Immunology

IL-22, not simply a Th17 cytokine

Sascha Rutz et al.

IMMUNOLOGICAL REVIEWS (2013)

Review Immunology

Recent advances in IL-22 biology

Lauren A. Zenewicz et al.

INTERNATIONAL IMMUNOLOGY (2011)

Article Oncology

Long-Term Survival and Late Deaths After Allogeneic Hematopoietic Cell Transplantation

John R. Wingard et al.

JOURNAL OF CLINICAL ONCOLOGY (2011)

Article Immunology

Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A

Gregory F. Sonnenberg et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2010)

Article Immunology

IL-22 Induces an Acute-Phase Response

Spencer C. Liang et al.

JOURNAL OF IMMUNOLOGY (2010)

Review Immunology

Intestinal mucosal barrier function in health and disease

Jerrold R. Turner

NATURE REVIEWS IMMUNOLOGY (2009)

Article Immunology

IL-22 increases the innate immunity of tissues

K Wolk et al.

IMMUNITY (2004)